Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > STOCK UPDATE

<< Previous

Bullboard Posts

Next >>

Comment by guerreiroon Feb 14, 2011 10:10pm

301 Views

Post# 18133255

RE: STOCK UPDATE

Great of you for the tip on HLO on your www.pennyalertsonline.com , you must have inside information about the on coming drilling results, coming soon. You are suggesting 300% as your recommendation on HLO, which would mean over $1.50. Keep us updated on your predictions and particularly your target on HLO of over $1.50 and indeed your free services.
As a long term shareholder of HLO and expecting to get my investment back. I thank www.pennyalertsonline.com for recommending HLO' s potentiality.
I am very happy on all the support that HLO receives from, HBM , PNP, andwww.pennyalertsonline.com

Best of luck, we have a winner. Just be patient.